Abstract

Kayexalate in Lactulose

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2021 - Volume 25, Number 6

Page(s): 501

Download in electronic PDF format for $75

Abstract

A formulation for preparing Kayexalate in Lactulose. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 323-324	Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Author(s): Quay Irene, Tan Edward
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2023 Pg. 420	Nitazoxanide 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 438-439	A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Mar/Apr 2017 Pg. 160-163	Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2003 Pg. 61	Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 58-59	Suspension Solution, Sugar Free Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 248	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 233-239	Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
Mar/Apr 2017 Pg. 105-108	Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Author(s): Benischek Rita
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 415	Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr